POPULARITY
Categories
About this episode: Can a spoonful of sugar really cure your hiccups? Can a dab of soy sauce soothe a burn? Is there any science behind home remedies? In this episode: Joe and Terry Graedon of The People's Pharmacy discuss some of their favorite, evidence-backed home remedies and how they balance alternative medicine with scientific data to promote wellbeing. Guests: Joe Graedon, MS, and Terry Graedon, PhD, are the award-winning authors, newspaper columnists, and podcast hosts behind The People's Pharmacy, an enterprise focused on sharing information on both medical and alternative health treatments. Host: Lindsay Smith Rogers, MA, is the producer of the Public Health On Call podcast, an editor for Expert Insights, and the director of content strategy for the Johns Hopkins Bloomberg School of Public Health. Show links and related content: The People's Pharmacy—http://peoplespharmacy.com Soy Sauce to the Rescue to Cool a Burn—The People's Pharmacy Should You Pour Black Pepper on Your Cut?—The People's Pharmacy Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @PublicHealthPod on Bluesky @JohnsHopkinsSPH on Instagram @JohnsHopkinsSPH on Facebook @PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
About this episode: Pharmacies do a lot more than dispense medications. In this episode: Christina Madison, known online as the Public Health Pharmacist, explains how pharmacists and pharmacies are able to support critical health needs in communities across the country. Guest: Christina Madison, PharmD, FCCP, is a clinical pharmacist and the founder and CEO of The Public Health Pharmacist, PLLC. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: The Public Health Pharmacist—http://thepublichealthpharmacist.com The Public Health Pharmacist—Instagram Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @PublicHealthPod on Bluesky @JohnsHopkinsSPH on Instagram @JohnsHopkinsSPH on Facebook @PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
Join us for an exclusive conversation with NCPA President Jeff Harrell, where we talk about the future of pharmacy and the leadership that's shaping it. Jeff shares how he and the NCPA team are working to reshape pharmacy education, advocate for fair reimbursement, and foster unity among owners everywhere. He also shares how he's scaling his own business, Cascadia Pharmacy Group, throughout the Pacific Northwest, and what he's learned along the way. Tune in for an insider's look at industry shifts, trends, and opportunities, and what they mean for pharmacies nationwide. Register today for NCPA Annual 2025 in New Orleans on October 18-21: https://ncpa.org/annual-convention Cascadia Pharmacy Group website: www.cascadiapharmacygroup.com Cascadia Pharmacy Group LinkedIn: www.linkedin.com/company/cascadia-pharmacy-group Jeff's LinkedIn: https://www.linkedin.com/in/jeff-harrell-a9670510/ Beyond Prescriptions: https://www.youtube.com/watch?v=F_4I_rR_ltU NCPA website: www.ncpa.org 00:00 – Welcome Back & Jeff Harrell Introduction 03:40 – Changing the Narrative in Pharmacy Schools 07:05 – The “Premium Gas” Analogy for Pharmacy 12:20 – Lessons from Around the World 27:00 – The Cascadia Model: Owning and Growing Smart 44:10 – Inside the Pharmacy: Efficiency, Systems, and Savings 49:25 – GLP-1 Challenges and Looking Ahead Hosted By: Mark Bivins | Chief Growth Officer, RedSail Technologies Guest: Jeff Harrell | President, NCPA Looking for more information about independent pharmacy? Visit https://www.redsailtechnologies.com
On this episode, we review irritable bowel syndrome (IBS) and describe its clinical presentations, subtypes, and pathophysiology. We discuss current guidelines and evidence-based treatment strategies for managing IBS, including pharmacological, dietary, and lifestyle interventions. We also compare and contrast the efficacy, safety profiles, and appropriate use of IBS therapies, including medications, dietary modifications, and symptom-specific management strategies. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. If you purchase an annual membership, you'll also get a free digital copy of High-Powered Medicine 3rd edition by Dr. Alex Poppen, PharmD. HPM is a book/website database of summaries for over 150 landmark clinical trials.You can visit our Patreon page at the website below: www.patreon.com/corconsultrx We want to give a big thanks to Dr. Alex Poppen, PharmD and High-Powered Medicine for sponsoring the podcast.. You can get a copy of HPM at the links below: Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to say thank you to our sponsor, Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx We also want to thank our sponsor Freed AI. Freed is an AI scribe that listens, prepares your SOAP notes, and writes patient instructions. Charting is done before your patient walks out of the room. You can try 10 notes for free and after that it only costs $99/month. Visit the website below for more information: https://www.getfreed.ai/ If you have any questions for Cole or me, reach out to us via e-mail: Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com
Celebrating the Launch of American Pharmacists Month 2025 “Caring for our Communities” This Week in Pharmacy (TWIRx) Friday, October 3, 2025 Episode Overview Today marks the kickoff of American Pharmacists Month 2025, a time to recognize the essential role pharmacists play across all healthcare settings. This special TWIRx episode spotlights leaders and innovators shaping pharmacy practice, technology, and patient care — and challenges the profession to embrace a 31-day journey of advocacy, community connection, and transformation. TWIRx NEWS Former Rep. Tiahrt: Pharmacy Benefit Manager bill could shut down CVS in Kansas | Opinion Read more at: https://www.kansas.com/opinion/guest-commentary/article312355904.html#storylink=cpy Neronha lawsuit against CVS Caremark can help save my Middletown pharmacy: Guest View https://www.newportri.com/story/opinion/columns/guest/2025/10/03/neronha-lawsuit-against-cvs-can-help-save-middletown-pharmacy-guest-view/86471928007/ FDA Approves Lurbinectedin Combination Regimen in Extensive-Stage SCLC https://www.pharmacytimes.com/view/fda-approves-lurbinectedin-combination-regimen-in-extensive-stage-sclc Building an Opioid Stewardship Program in Cancer Care: Pharmacist Roles, Challenges, and Patient Safety https://www.pharmacytimes.com/view/building-an-opioid-stewardship-program-in-cancer-care-pharmacist-roles-challenges-and-patient-safety Featured Guests Dr. Jesse McCullough, PharmD Founder, Keystone Pharmacy Insights Introducing the American Pharmacists Month 31-Day Challenge, a call to action for pharmacists to engage, educate, and elevate their communities. Bil Schmidtknecht Patient Protector Sharing insights on patient advocacy, protecting access to care, and the pharmacist's role in navigating today's healthcare complexities. Dr. Devin Bustin, MD Chief Medical Officer, OvaryIt Dr. Lissette Logan, PharmD COO, OvaryIt Together, Dr. Bustin and Dr. Logan discuss innovative pharmacist-driven care models, treatment tracking, and platforms like PRISM designed to ensure pharmacists are recognized — and reimbursed — for their expertise. Dr. Jill Kolesar, PharmD Dean, College of Pharmacy, The University of Iowa Highlighting the future of pharmacy education and how academia is preparing the next generation for expanded clinical and community roles. Dr. Jason Lang, PharmD Wellgistics Exploring the logistics and supply chain innovations that keep pharmacies agile in serving patient needs, especially as new therapies and technologies emerge. WELLGISTICS News: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/wellgistics-health-nasdaq-wgrx-and-theracosbio-partner-to-expand-nati-1079815 SUBSCRIBE TO TWIRx HERE: https://open.spotify.com/show/52NZjr9asE8fLrrbsMvBlQ Celebrating the Launch of American Pharmacists Month 2025 | TWIRx
“I think that this is an area that is exploding. Working with drug development, I see new agents all the time, with unique targets I've never heard about, with targets I have heard about used in a different way. So, I really think we're going to see more and more bispecifics. A lot of these drugs are used second line, third line, fourth line. I would not be surprised if they moved up in treatment, especially as we learn safer ways to give these drugs,” ONS member Moe Schwartz, PharmD, BCOP, FHOP, professor of pharmacy practice at the James L. Winkle College of Pharmacy at the University of Cincinnati, OH, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about bispecific antibodies. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by October 3, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learner will report an increase in knowledge related to the use of bispecific antibodies in the treatment of cancer. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 275: Bispecific Monoclonal Antibodies in Hematologic Cancers and Solid Tumors Episode 261: CAR T-Cell Therapy for Hematologic Malignancies Requires Education and Navigation Episode 176: Oncologic Emergencies: Cytokine Release Syndrome ONS Voice articles: An Oncology Nurse's Guide to Bispecific Antibodies Bispecific Antibodies Cross-Discipline Cancer Care ONS Voice oncology drug reference sheets: Amivantamab-Vmjw Blinatumomab Epcoritamab-Bysp Glofitamab-Gxbm Mosunetuzumab-Axgb Tebentafusp-Tebn Teclistamab-Cqyv ONS book: Guide to Cancer Immunotherapy (second edition) ONS course: ONS/ONCC® Chemotherapy Immunotherapy Certificate™ Clinical Journal of Oncology Nursing article: Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Other ONS resources: Bispecific Antibodies Video Bispecifics Huddle Card Cytokine Release Syndrome Huddle Card Immune Effector Cell–Associated Neurotoxicity Syndrome Huddle Card DailyMed homepage Hematology/Oncology Pharmacy Association late-breaking news article: The Emerging Use of Bispecific Antibodies with Chemotherapy in Diffuse Large B-Cell Lymphoma To discuss the information in this episode with other oncology nurses, visit the ONS communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org Highlights From This Episode “It was 2014 that most of us think of as the beginning of bispecifics in cancer, and that was with approval of blinatumomab. That was granted accelerated approval for the treatment of patients with Philadelphia chromosome–negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia. It is a bispecific that targets CD19-expressing tumor cells and CD3 on T cells. It's the original bispecific T-cell engager and is often called a ‘BiTE.'” TS 2:11 “The term ‘bispecific' means that this is an artificial protein that's developed to hit two different antigens simultaneously. They can be two different epitopes on the same antigen. They can be an antigen on a cancer cell and CD3 on a T cell that kind of recruits the T cell to the cancer. So, there are different types [of bispecific antibodies]. The subtype that we often talk about are bispecific T-cell engagers, which are those bispecifics that do target the T cell. And currently, the target on the T cell that's utilized is the CD3 molecule. That's not the only one that will be used in the future because there's a lot of work being done on other types of T-cell engagers.” TS 4:21 “The targets for lymphoma are CD20. Those are bispecific T-cell engagers that hit CD20 on the lymphoma cell, as well as CD3 on a T cell. ... In myeloma, we have two different targets that have been utilized. One is BCMA or B-cell maturation antigen. That sits on the surface of myeloma cells and on some healthy B cells. ... There's also a target used in myeloma that's called GPRC5D, which stands for G protein–coupled receptor, class C, group 5, member D. ... In small cell lung cancer, there's delta-like ligand 3 (DLL3); it's part of the NOTCH pathway. ... And then this year, we've had a couple agents come out that target HER2.” TS 6:52 “[Toxicities] are very dependent on what your target is. ... The bispecific T-cell engager that's used in myeloma that targets the GPRC5D is also expressed on tissues that produce hard keratin like hair follicles and actually, within the tongue. So the toxicities that we see with that agent are something you wouldn't expect to see if you were using a myeloma agent. You see nail and skin issues. You see taste problems. So it's very specific about the target, which says to me, that every time a new one of these agents comes out, I have to learn about the target that helps me learn about the toxicity. I find that fascinating and really appreciate that.” TS 16:19 “Cytokine release syndrome has been one of the areas that drug development has really focused on to see how they can help mitigate the severity [of it]. ... [One of] the strategies that has been incorporated and studied in clinical trials is the step-up dosing scheme. [It's] where you give initial small doses and over time, increase the dose to the dose you're going to continue with. Usually, monitoring in the hospital is required by the FDA approval for anywhere from 28–48 hours for the first couple of doses. And that's a real common strategy that you'll see. Premedication with H2 blockers, H1 blockers, sometimes steroids. These are also things that are incorporated within the approvals of these drugs and are important to look at.” TS 20:53
GLP-1 therapies are transforming pharmacy benefits, and Express Scripts is leading the way. Harold Carter, PharmD, SVP of Trade Relations, joins host Eric Glazer to discuss how one of the nation's largest PBMs is navigating this disruptive moment in healthcare. Harold shares how Express Scripts is: Capping costs of GLP-1 therapies to expand patient access while keeping plan spending predictable. Redesigning funding models to strike a balance between affordability, predictability, and outcomes. Leveraging digital tools and AI to reduce friction in the member experience and support long-term adherence. Rethinking formularies not just as cost-control tools but as part of a broader population health and behavioral change ecosystem. You'll also hear his forward-looking perspective on how PBMs will evolve over the next three to five years, and the key questions health plans and employers should be asking today to prepare for the future of pharmacy benefits. About Dr. Harold Carter: Harold Carter, PharmD, is responsible for leading all interactions and contracting with pharmaceutical manufacturers and oversees strategy and management of Express Scripts' drug formularies, data & insights, client underwriting, and product strategy and development. In his nearly 14 years with the organization, Harold has held numerous leadership roles oriented around critical efforts to lower the cost of prescription drugs and ensuring medication access for Express Scripts clients and members. Harold's previous responsibilities include oversight of the organization's medical pharma contracting and drug procurement teams, as well as leading the strategy, development and execution of Express Scripts' wholesale market, value-based solutions and generic strategy, and development of Express Scripts' advanced utilization management solutions. In addition to his work at Express Scripts, Harold serves on numerous boards including LifeWise Stl Board of Directors, St. Louis University High School Board of Trustees and IVI Board of Directors. Harold earned his doctorate in pharmacy from St. Louis College of Pharmacy. Partner with Bright Spots Ventures: If you are interested in speaking with the Bright Spots Ventures team to brainstorm how we can help you grow your business via content and relationships, email hkrish@brightspotsventures.com About Bright Spots Ventures: Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the “bright spots” in healthcare, proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com.
Send us a textWelcome back Rounds Table Listeners! We are back today with a solo episode with Dr. John Fralick. This week, he discusses a recently published trial examining fecal microbiota transplantation (FMT) in primary C. difficile infection. Here we go!Fecal Microbiota Transplantation Versus Vancomycin for Primary Clostridioides difficile Infection: A Randomized Controlled Trial (0:00 – 4:47).The Good Stuff (4:48 – 5:36):The I'm Pharmacy podcast, now featured on https://medicinepods.com/im-pharmacy/.Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods
Good communication isn't optional—it's essential for patient care. In Part 1 of this two-part series, Dr. Erin McCreary and Dr. Hannah Creager join Luis to talk about how microbiology labs and antimicrobial stewardship teams can collaborate more effectively. They share real-world examples from their system-wide work—aligning AST panels and breakpoints across multiple platforms, navigating reporting challenges like the clindamycin D-test and rifampin comments, and building consistent communication through monthly micro–stewardship meetings. It's a behind-the-scenes look at how strong collaboration turns into better patient outcomes. Stay connected with Let's Talk Micro: Website: letstalkmicro.com Questions or feedback? Email me at letstalkmicro@outlook.com Support the podcast: Venmo Buy me a Ko-fi
In this episode, Tamara sits down with Carrie Krebs, PharmD, to talk about the important role pharmacists play in hospice care. Together, they cover commonly used medications, key regulations, deciding when to stop certain drugs, and more. Carrie also opens up with a personal story about her own loved one's hospice journey.
In this episode of The Birth Lounge Podcast, HeHe sits down with clinical pharmacist Dr. Michaela Wachal to unpack the controversy surrounding Tylenol (acetaminophen) use in pregnancy and its potential links to autism and other neurodevelopmental concerns. Together, they dive into what the research actually says (and doesn't say), why transparency and informed consent are so important, and how to navigate decisions around medications in pregnancy with confidence. Dr. Wachal also highlights the bigger picture, like how genetics, environmental toxins, and even maternal stress can play a role in outcomes, and why caring for yourself is just as critical as any prescription. This conversation is packed with nuance, evidence, and practical takeaways to help you feel informed, empowered, and ready to advocate for yourself as you make decisions about your pregnancy care. 00:00 Introduction and Media Misrepresentation 01:05 Personal Story and Birth Lounge App 02:16 Empowering Prenatal Conversations 05:26 Emergency Use Authorization Episode 07:34 Interview with Dr. Michaela Wachal 09:14 Medication Safety in Pregnancy 12:37 Pharmaceutical Industry Failures 15:20 Personal Journey and Advocacy 18:55 Questioning Medical Norms 21:15 Tylenol and Toxins 23:34 Aluminum in Vaccines 27:32 The Importance of Transparency 37:05 Advocating for Education and Understanding 37:51 The Power of Asking Questions 40:21 Nesting and Preparing for Baby 43:17 Managing Fevers During Pregnancy 52:01 Environmental Toxins and Health 01:00:41 Therapies and Support for Children on the Spectrum 01:09:27 Final Thoughts and Encouragement Guest Bio: Michaela Wachal, PharmD, CSP, is a clinical pharmacist, Certified Specialty Pharmacist, and Clinical Accreditation Manager with nearly a decade of experience in specialty pharmacy. She holds a Doctor of Pharmacy degree from the University of Nebraska Medical Center and a Bachelor of Science in Biochemistry from Doane University. Throughout her career, she's specialized in complex conditions including oncology, fertility, endocrinology, immunology, mental health, and inflammatory diseases—always with a passion for improving patient care, optimizing healthcare systems, and empowering women in medicine. Michaela is also a mom of three, including one child with autism, ADHD, and anxiety, which ignited her deep interest in neurodiversity, integrative health, and individualized medicine. After navigating her own family's challenges, she began researching functional and evidence-based approaches to support children and families living with complex needs. Online, Michaela shares insights from scientific studies on autism, ADHD, vaccines, autoimmune conditions, toxins, and more, always with a focus on helping parents make informed, evidence-based choices. Her work blends professional expertise with personal passion, making her a trusted voice in both the pharmacy world and the parenting community. INSTAGRAM: Connect with HeHe on IG Connect with Dr. Wachal on IG BIRTH EDUCATION: Join The Birth Lounge here for judgment-free childbirth education that prepares you for an informed birth and how to confidently navigate hospital policy to have a trauma-free labor experience! Download The Birth Lounge App for birth & postpartum prep delivered straight to your phone! RESEARCH MENTIONED: 2021 there's a call for action published supported by 91 scientists, clinicians and public health professionals across the globe recommended that pregnant women should be cautioned at the beginning of pregnancy to forego APAP unless it is medically indicated and to minimize the exposure by using the lowest effective dose for shortest possible time https://pubmed.ncbi.nlm.nih.gov/34556849/ Boston Birth cohort published in 2020 looked at acetaminophen metabolites in cord blood samples collected at birth and unchanged acetaminophen levels were detected in all cord plasma samples and acetaminophen burden was associated with higher odds of ADHD and ASD daignosis there was a 2.3 to 3.5 increased risk for ADHD and 1.6 to 4.1 increased risk for ASD https://pubmed.ncbi.nlm.nih.gov/31664451/ Recently in August Harvard did an analysis using the Navigation Guide methodology that supports evidence consistent with an association between acetaminophen exposure during pregnancy and increased incidence of Neurodevelopmental disorders. This included 46 studies with 27 reporting positive associations with the higher quality studies more likely to show positive correlations https://ehjournal.biomedcentral.com/articles/10.1186/s12940-025-01208-0 Nurses Health Study https://pubmed.ncbi.nlm.nih.gov/30923825/ Spanish birth cohort where acetaminophen exposure was associated with more hyperactivity/impulsivity https://pubmed.ncbi.nlm.nih.gov/27353198/ In 2018 there was a review that showed that 9 prospective cohort studies that all suggested an association between prenatal APAP exposure and neurodevelopmental outcomes - ADHD, ASD or lower IQ and longer duration was associated with increased risk https://pubmed.ncbi.nlm.nih.gov/29341895/ 2022 a prospective cohort study in Pennsylvania looked at 2,423 moms using data and children who were exposed to APAP during pregnancy scored higher for child behaviors, sleep problems and attention problems https://pubmed.ncbi.nlm.nih.gov/36170224/ Keywords: Tylenol pregnancy, acetaminophen pregnancy, Tylenol autism risk, pregnancy medication safety, prenatal care, evidence-based pregnancy, maternal health, neurodevelopment, pregnancy decision making, informed consent pregnancy, pregnancy medications, Dr. Michaela Wachal, Birth Lounge podcast, pregnancy self-care, pregnancy toxins
Mississippi Department of Health confirms a 2-month-old has died from pertussis, often called Whooping Cough. The state health officer is urging adults to keep their booster shots up to date. Then, the gross domestic product is down by nearly 1 percent in the state. What that means for the economy ahead.Plus, Pharmacies in Louisiana are making their own rules about who can get a COVID-19 vaccine amid confusion around official guidance. Hosted on Acast. See acast.com/privacy for more information.
Cold and flu season is back. This is a good time to check in with our favorite virologist, Dr. Eric Yager of the Albany College of Pharmacy and Health Sciences. Ray Graf hosts.
Financial pressures, reimbursement challenges, and adapting to new regulations Brian reflects on his transition from VP at Bi-Mart to owner of Caris Pharmacy, sharing insights on managing margins, operations, and strategy Spotlight on Indiana's Disclosure of Actual Acquisition Cost (Indiana Code § 27-1-24.2) effective Jan 1, 2026, and what it means for independents and regional chains alike
This episode dives into the future of pharmacy through the lens of pharmacogenomics (PGx). Dr. Melissa Smith speaks with Dr. Vanessa Lesneski about the steep decline in pharmacy school enrollment and how PGx could reignite interest in the profession. They explore how PGx has rapidly evolved from an elective to a core component of pharmacy education, the rise of certification and training pathways, and the expanding career opportunities in diverse care settings. The discussion also tackles critical questions around pharmacists' role in test interpretation, skepticism about PGx adoption, and what it will take for the field to move from niche to mainstream.
What does it truly mean to be successful in medicine? This episode features Dr. Valentin Calu, an Associate Professor of Surgery from Romania, who shares his profound journey from a near-fatal plane crash during an organ harvest mission to his powerful return to the operating room. Discover a unique perspective on surgical leadership, the importance of mentorship, and the deep personal growth required to thrive in high-stakes medical environments. Dr. Calu provides his definitive "Prescription for Success," a ten-point framework built on discipline, team value, and self-awareness. This conversation is essential for any medical professional seeking to build a resilient, impactful, and fulfilling career beyond clinical skill alone. Key Topics Discussed: The long pathway to becoming a surgeon and the transformational journey of residency. Overcoming a life-altering trauma and the mental shift from being a caregiver to a patient. Redefining success as a combination of calling, discipline, and consistency. The critical importance of humility, teamwork, and leading by example in the operating room. Strategies for maintaining physical health to fuel mental clarity and surgical performance. The philosophy of leaving a legacy through teaching and inspiring the next generation. Practical advice on time management, prioritization, and achieving work-life balance. Featured Expert: Dr. Valentin Calu is an Associate Professor of Surgery and Pharmacy at Carol Davila University in Bucharest, Romania. He is a respected HPB surgeon and a passionate educator dedicated to surgical excellence and mentorship. Relevant Keywords: surgeon leadership, physician burnout, medical career development, surgical residency, overcoming adversity, medical mentorship, work life balance for doctors, patient safety, operating room team, clinical resilience, medical legacy, healthcare leadership, physician coaching, surgical training, professional development for physicians, medical education, doctor patient relationship, hospital culture, success in medicine. Subscribe for more conversations with exceptional medical professionals on leadership, career transition, and personal growth.
In this episode of the Any Given Runday podcast, Rob Dwyer (@rob__dwyer on Instagram) shares his journey from hurling to triathlon, detailing his experiences in various competitions, including Ironman Wales and the Triathlon World Championships. He discusses the challenges he faced, particularly in swimming, and the importance of coaching and proper nutrition. Rob also opens up about his health struggles, including hemochromatosis and the impact of relative energy deficiency syndrome (RED-S) on his training. As he looks to the future, Rob emphasises the importance of recovery and setting goals in his athletic journey.13:30 Introduction to Rob Dwyer and His Journey15:44 Transition from Hurling to Triathlon19:46 The First Triathlon Experience22:16 The Lifestyle of Triathlon23:41 Swimming Challenges and Flowstate Swimming25:08 Preparing for the Ironman in Wales26:56 Cycling Strategy and Execution29:49 Running the Marathon After the Bike32:28 Reflections on the Ironman Experience33:19 The Transition from Cycling to Running34:39 Mental Preparation for the Marathon35:40 The Ironman Experience: Grit and Determination38:09 Post-Ironman Reflections and Next Steps39:17 Competing at the World Championships41:58 The Reality of Competing with Elite Athletes43:10 Understanding RED-S and Its Impact48:30 Nutrition and Recovery Strategies55:28 Mindset During Competition and Recovery60:14 Future Plans and Goals in TriathlonYou can follow us on Instagram@anygivenrundaypodcastThis episode is sponsored by ULTRAPURE Laboratories and their new Sports Recovery Kit. Ask for the ULTRAPURE Laboratories Muscle Recovery range in your local Pharmacy or Health Store or visit their new online storeUltrapurelabs.ie You can now get 20% off all Perform Nutrition products, including their new Carb Gels, using the code 'AGR' at checkoutPerformNutrition.com
On "This Week in Pharmacy" for September 26th, we're talking about Trust in Healthcare, World Pharmacists Day, and Cell & Gene Therapy. Today's co-host is Dr. Melissa Smith, PharmD CPH with Florida PGx Consulting LLC. https://www.floridapgxconsulting.com/ First, #TWIRx News - the FDA approves Inluriyo imlunestrant on 9/25/2025 which is to treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, estrogen receptor-1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy. (https://www.fda.gov/drugs/novel-drug-approvals-fda/novel-drug-approvals-2025) Second, Nested-Knowledge - is going to revolutionize information access and leverage. This is a powerful tool with evidence synthesis tools for medical researchers. This will help accelerate, collaborate, automate and share the latest and personalized treatment plans. (https://nested-knowledge.com/) Next, announcing "Evidence based Podcasting", the new standard in audio learning for Providers and next level in podcast Continuing Medical Education (CME). (https://pharmacypodcast.com/2025/09/26/evidence-based-podcasting-and-the-future-of-medical-education/ ) Shout out to Nick Calla with Orsini, a leader in rare disease pharmacy solutions, has been chosen by Crinetics Pharmaceuticals, Inc., as a specialty pharmacy partner for PALSONIFY™ (paltusotine), a nonpeptide, selectively-targeted somatostatin receptor type 2 nonpeptide (SST2) agonist. (https://www.wvnews.com/news/around_the_web/partners/pr_newswire/subject/licensing_marketing_agreements/orsini-selected-as-specialty-pharmacy-partner-for-crinetics-palsonify-paltusotine/article_9b42bfe7-69a6-58be-98ff-5e2245145415.html) Today we have two guest Pharmacists to dig into the "Trust in Healthcare" theme of today's #TWIRx -- the godfather of Functional Pharmacy Robert Kress RPh., and Dr. Lauren Castle, PharmD, MS, AFMC - Founder & CEO of Functional Medicine Pharmacists Alliance. Who do you trust? What information is trustworthy and why? Our special feature is updates on 'Cell & Gene Therapy' with McKesson's Head of Cell Gene Advanced Therapies, Joe DePinto at InspiroGene! (https://inspirogene.com/) Today's TWIRx is sponsored by 'Sykes & Company' the Pharmacy Accounting Jedi Masters and Independent Pharmacy Cooperative (IPC) and how they're revolutionzing digital health and new revenues with the iCare+ System! Trust Matters, Cell and Gene, & World Pharmacists Day | TWIRx
Pharmacy didn't start with white coats and sterile counters—it began with beer, clay tablets, and a lot of very questionable ingredients. In this episode of For the Love of History, we dive into the weird, messy, and fascinating history of pharmacy. From Neanderthals using flowers as medicine to the Egyptians prescribing crocodile dung in the Ebers Papyrus, the path to your neighborhood drugstore is packed with strange detours. We'll explore how our ancient ancestors shaped pharmacology with herbs and magic, why the gods were involved in medicine, and how Hippocrates sparked a medical revolution. Finally, we'll explore some of the oddest remedies you'll find in history's medicine cabinet! Pharmacy history is full of odd cures, magic, and surprising innovations. By the end of this episode, you'll never look at a prescription the same way again.
Discover expert insights on kidney stone prevention and management in this podcast episode featuring a physician, dietitian, pharmacist, and patient. Learn about key kidney stone risk factors and explore how dietary adjustments can reduce stone recurrence. Experts discuss fluid intake strategies, medication considerations, surgical indications, and even unconventional questions about roller coasters' impact on stone passage. Tune in for actionable advice, myth-busting discussions, and interprofessional perspectives. On today's episode we heard from: Melanie Betz, MS, RD, CSR, FNKF, FAND is a nationally recognized renal dietitian and the Founder & CEO of The Kidney Dietitian. She is a Certified Specialist in Renal Nutrition and a Fellow of both the National Kidney Foundation and the Academy of Nutrition & Dietetics. Melanie has published extensively on kidney stone prevention and nutrition, and has presented at numerous state, national, and international conferences on the topic. Through her clinical work, research, and educational outreach, she is dedicated to helping patients and professionals understand the critical role of diet in kidney health. Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS is a Clinical Associate Professor at West Virginia University School of Pharmacy and a Clinical Pain & Addiction Pharmacist. With expertise in pain management, substance use disorders, and geriatric care, he brings both clinical and personal perspectives to kidney stone discussions. Mark has shared his experience through the Pain Pod podcast, PAINWeek presentations, and a published article detailing his own kidney stone journey. Mary Raines, CRA is a retired clinical research associate with more than 30 years of experience in medical research. After learning she needed a kidney transplant, she dedicated herself to advocacy and now serves as a Patient Advocate with the National Kidney Foundation and other kidney health organizations. Mary brings both professional expertise and personal experience to her work, amplifying the voices and needs of people living with kidney disease. Andrew Rule, MD, MSc is a Professor of Medicine and Consultant Nephrologist at the Mayo Clinic in Rochester, Minnesota. He divides his time between clinical care, research, and education, with a particular focus on kidney stone disease and its link to chronic kidney disease. Dr. Rule has published extensively on the epidemiology of kidney stones and provides specialized care in the Mayo Clinic's nephrology stone clinic. Bryan Tucker, DO, MS, FASN is an Assistant Professor of Medicine in Nephrology at Baylor College of Medicine, where he serves as a clinician educator teaching medical students, residents, and fellows while caring for patients in both inpatient and outpatient settings. He holds a master's degree in nutrition from Columbia University and completed his nephrology fellowship at Yale. A Fellow of the American Society of Nephrology, Dr. Tucker has authored numerous peer-reviewed publications and book chapters and is an active contributor to The Kidney Commute podcast. Additional Resources: Kidney Stone Information Earn CME Credit Here Do you have comments, questions, or suggestions? Email us at NKFpodcast@kidney.org. Also, make sure to rate and review us wherever you listen to podcasts.
In this episode of the Astonishing Healthcare podcast, host Justin Venneri is joined by Josh Golden, SVP of Strategy, and RFP Content Manager, Nic Bolitho, for a timely discussion about trends they're seeing in the market and how to run a better request for proposal (RFP) process to select a pharmacy benefit management (PBM) partner. Long story short, the "old way" of running a PBM RFP is broken, but, as Josh describes, there are some "tectonic shifts" happening as plan sponsors demand to see more options (i.e., transparent PBMs) and benefits brokers and consultants upgrade the questions and scoring used to force accountability and drive meaningful results for plans and plan members.HighlightsUnit-cost-based spreadsheet comparisons and marketing fluff are "out;" evaluating drug mix and how the PBM manages the plan (the 'M' in PBM) or makes money off of the plan are "in."Plan sponsors and benefits consultants must demand flexibility - the PBM contract should not be a "house of cards." For example, agreements should provide the freedom to add new vendors or carve out services without collapsing your financial arrangement.Legacy tech platforms are a barrier to innovation; ask potential partners if their technology can handle customizations and integrations with agility to avoid being told, "We just can't do that."Precise questions about member experience are a must; RFPs should move beyond open-ended questions that invite marketing fluff. Use specific, binary questions to obtain an accurate measure of the member experience and the effectiveness of clinical programs (e.g., NPS, turnaround times for prior authorizations, etc.).Related ContentReplay: PBM Procurement Decoded: Insights from a Pharmacist and an Actuary Why Savings Don't Materialize: The Truth About Pharmacy Benefit Procurement eBook AH034 - Customer Care in Healthcare: Setting a Higher Bar, with Will TafoyaAH035 - Pharmacy Benefits 101: Clinical Programs, with Bonnie Hui-Callahan, PharmD5 ways to improve PBM procurement (EBN) For more information about Capital Rx and this episode, please visit Judi Health - Insights.
PeerView Family Medicine & General Practice CME/CNE/CPE Video Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.
Too many pharmacy owners chase growth and revenue—only to find themselves stressed, underpaid, and struggling with cash flow. In this episode, Dr. Lisa Faast shares why profit is the new growth and why shifting your mindset from vanity metrics to bottom-line results is the only way to build a sustainable, thriving pharmacy. **Show Notes:** 1. **Introduction** [0:00] 2. **Understanding the New Member Box and Its Message** [1:06] 3. **The Importance of Profit Over Revenue** [4:12] 4. **Optimizing Operations for Profit** [4:32] 5. **Conclusion and Call to Action* [6:20] ----- #### **Becoming a Badass Pharmacy Owner Podcast is a Proud to be Apart of the Pharmacy Podcast Network**
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.
PeerView Family Medicine & General Practice CME/CNE/CPE Audio Podcast
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/TZU865. CME credit will be available until September 15, 2026.Don't Miss Hidradenitis Suppurativa: Providing Timely Diagnosis and Management Using Novel AgentsPurdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.This accredited activity has been developed in collaboration with our educational partner, PVI, PeerView Institute for Medical Education.SupportThis activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.
In this week's Omni Talk Retail Fast Five, sponsored by the A&M Consumer and Retail Group, Mirakl, Ocampo Capital, Infios, and Quorso, A&M's Joanna Rangarajan and Mohit Mohal joined Chris and Anne to analyze Walmart's groundbreaking move to deliver refrigerated and reconstituted prescriptions nationwide. From GLP-1s to insulin and pediatric medications, discover why our experts scored this move between 8-11 out of 10 for significance. We explore the convenience factor, competitive implications for CVS and Walgreens, and how this positions Walmart in the massive healthcare market. Tune in for expert insights on retail's healthcare evolution! #ecommerce #retailfulfillment #Walmart #rx #pharmacy
Iowa and other states have recently passed laws that aim to help small, local pharmacies stay open. Also, a University of Iowa professor has launched an app to help first responders communicate with patients who are nonverbal or don't speak English.
ASHP's senior education director, Cindy Von Heeringen is joined by James Hoffman, senior vice president of quality and safety, member, pharmacy and pharmaceutical sciences at St. Jude Children's Research Hospital, and Joe DiPiro, professor emeritus at Virginia Commonwealth University, School of Pharmacy, as they discuss their upcoming Midyear session that focuses on relevant trends in the external environment that will have a major impact on health-system pharmacy practice over the next five years. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Send us a textSchedule an Rx AssessmentSubscribe to Master The MarginGrowing your pharmacy without losing your people along the way can be tricky but not impossible.On this week's episode of the Bottom Line Pharmacy Podcast, we tackle one of the most pressing challenges multi-store pharmacy owners face today: People operations at scale.In this conversation, we have a full crew of Sykes team members featuring Scotty Sykes, CPA, CFP®, Bonnie Bond, CPA, MBA, Austin Murray, Marketing Director and Tyler Davis, Director of People Operations, to unpack the realities of managing HR in a multi-store pharmacy world. We cover:- Why transitioning to multi-store operations creates new compliance hurdles- How engagement programs and stay interviews strengthen retention- Why recognition matters just as much as (or more than) compensation- Why investing in HR early can be key to sustainable growthAnd more!Stay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterOllin Sykes, CPA, CMA, CITP LinkedIn
Today, we're hear a conversation between Rebecca Grandy, Director of Pharmacy at CHESS and Debi Hueter, Executive Director of WakeMed Key Community Care, a clinically integrated network focused solely on primary care. Discover how integrating pharmacy services is transforming provider workflows, reducing emergency visits, and improving patient outcomes.
On this episode of IPA's What, Why & How podcast, IPA CEO Matt Pitlick welcomes Anne Schlepphorst, Bureau Chief of Monitoring and Executive Director of the Iowa Board of Pharmacy, for an update from the Board, covering standard of care, immunizations, and more. Anne Schlepphorst serves as the Executive Director of the Iowa Board of Pharmacy, Interim Executive Director of the Iowa Board of Nursing, and Monitoring Bureau Chief. Anne has worked with the boards for the past seven years, most recently serving as the Chief Investigator for the Iowa Boards of Pharmacy and Medicine. When not working, Anne and her husband spend most of their time at the baseball field, hockey rink, wrestling mat, or football field watching their two teenage boys. Connect with us on LinkedIn: Anne Schlepphorst Matthew Pitlick Iowa Pharmacy Association
In this episode, Jamie Leonard shares her journey from clinical pharmacist to Director of Pharmacy at Benefis Health System in Great Falls, Montana. She oversees pharmacy operations across the continuum of care, including acute care, cancer and infusion centers, long-term care, critical access hospitals, and Benefis' 340B program. Jamie discusses the unique challenges of serving a largely rural and government-payer-heavy population, while emphasizing Benefis' strong commitment to community health, education, and work-life balance. She highlights key pharmacy initiatives such as expanding specialty and retail pharmacy, growing a Meds-to-Beds program, and supporting patients with timely medication access—critical in a state where patients often travel long distances.
Ever wondered what it's really like to invite and host a legislator at your Pharmacy?In this episode of Independent Insights, we sit down with Shannon Tesini, a Certified Pharmacy Technician and passionate pharmacy advocate, to demystify the process of preparing for a legislative visit. Whether you're a technician, pharmacist, or pharmacy owner, Shannon shares what it takes to confidently represent your profession and your patients at the policy level.You'll learn:What to expect before, during, and after a legislative meetingHow to prepare your message and make it personal and powerfulTips for staying calm, clear, and confident—even if it's your first timeWhy advocacy isn't just for pharmacists—and how technicians can lead the chargeIf you've ever thought, “I care, but I don't know where to start,” this episode is your roadmap to becoming a pharmacy advocate who makes a difference.HostSuzanne Feeney, PharmDVP, Pharmacy Retail OperationsMcKesson, Health MartGuestsShannon Tesini, CPhT Pharmacy TechnicianMcNabb PharmacyResourcesTune into Episode 16: Creating Pharmacy's Future where APhA President and Health Mart pharmacy owner Randy McDonough joins McKesson Health Mart's Chief Pharmacist Nancy Lyons for a candid conversation about the urgent changes needed in pharmacy—and the bold vision that can lead us forward.Health Mart Pharmacies can access Health Mart University (HMU) for: Helpful CE courses and more on pharmacy advocacyHealth Mart pharmacists to claim their CE credit for weekly GameChangers episodes The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.
Pooja Babbrah, executive vice president of strategy and industry alignment at NCPDP, discusses how her organizations' standards are making a meaningful difference in the pharmacy industry.
What if I told you that diabetes doesn't have to be a life sentence? In this episode of the Visibly Fit Podcast, I sit down with Timothy Keller, who went from facing a devastating diabetes diagnosis to completely reversing it—without relying on a stack of prescriptions.Tim shares his raw and real journey, from unhealthy habits and a shocking lab report to discovering the healing power of God's design through whole foods and lifestyle medicine. Not only did he restore his own health, but he also founded U.S. Diabetes Care to help thousands of others break free from the cycle of “sick care” and step into true health.This conversation is so much more than just about diabetes. It's about hope, faith, and realizing that your health choices impact generations to come. Whether you're facing a diagnosis, struggling to make lasting changes, or simply want to prevent disease and feel your best, this episode will give you both the inspiration and the tools to take charge of your health.Chapters:[00:00] Podcast Preview[01:34] Topic and Guest Introduction[05:10] Tim's Personal Health Journey[08:32] The Birth of U.S. Diabetes Care[12:45] Revolutionizing Diabetes Education[16:08] Understanding Diabetes Types[20:02] The Emotional Aspect of Health[23:30] Encouraging Change in Others[26:04] Telehealth and Accessibility[30:05] Continuous Glucose Monitoring Technology[33:50] Tim's Bold Final Encouragement[37:38] Final Thoughts and ResourcesResources mentioned:
September 22, 2025- New York policymakers looking to regulate the marketing of Kratom aren't making carveouts for "natural" products, which is a mistake, according to Dr. C Michael White, a department head at the University of Connecticut School of Pharmacy.
340B savings do not just enable hospitals to provide more care, they also help hospitals pioneer innovative approaches to bringing care directly to patients. For West Virginia University Medicine, which serves a high population of Medicare and Medicaid patients, one of these 340B-funded innovations came from recognizing a need to increase cancer screening rates. WVU Medicine 340B Enterprise Director Karen Famoso tells us how the system's mobile cancer screening initiative came about.The Barriers to Cancer ScreeningWVU Medicine identified that some of the biggest social determinants of health for its West Virginia patients were relatively unique to the areas it serves. The rural state has significant travel barriers, small population areas, and high poverty rates, a combination that leaves thousands of patients without easy access to a source of primary care.Mobile Screenings Look for Breast, Lung CancersToday, WVU Medicine operates two types of mobile cancer projects: Bonnie's Bus and LUCAS. The former launched in 2009 and is a mobile mammography unit named after a patient who died because she had limited access to breast cancer screenings. Her family donated funding to the hospital to support this effort. More than a decade later, WVU Medicine introduced the mobile lung screening program LUCAS. That initiative provides low-dose CT scans to patients meeting the screening guideline using a nearly 70,000-pound tractor trailer.340B Is Key To Sustaining Mobile Screening EffortsFamoso says WVU Medicine funds its mobile cancer screening programs through grants and donations, but that is not enough to cover the full cost. That is where 340B savings can help cover the operating loss, which was almost $400,000 last year. Without those 340B savings, the health system's financial situation would not allow investments in mission-focused programs such as Bonnie's Bus and LUCAS.ResourcesLung Cancer Screening on WheelsHRSA Reviewing Rebate Pilot Proposals and CommentsSecond Federal Appeals Court Upholds State Contract Pharmacy Law
In this podcast, members of the Pharmacy Administration and Leadership Residents' Collaborative explore disruptive innovations with Dr. Nishaminy Kasbekar and consider future implications as we work to expand medication access. Speakers discuss how these changes are transforming drug procurement, addressing challenges like drug shortages, and improving medication affordability for patients. Dr. Kasbekar also shares insights on how models like those adopted at her own institution could shape the future of pharmacy practice across health systems nationwide. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Join Drs. Neil Skolnik and Sara Wettergreen as they answer one of the most common questions people living with diabetes have: “What diabetes medication is best for me?” In this episode, they'll explore how choosing the right medication depends on your individual health, lifestyle, and goals. Discover practical tips to better help you work with your care team to make informed decisions and find the best treatment plan for you. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health, Abington, PA Sara Wettergreen, PharmD, BCACP, BC-ADM, Assistant Professor, Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; and Ambulatory Care Clinical Pharmacist, UCHealth Lone Tree Primary Care, Aurora, CO Do you have questions or comments you'd like to share with Neil and Sara? Leave a message at (703) 755-7288. Thank you for listening, and don't forget to “follow” Diabetes Day by Day! Diabetes Medications: Biguanides Brand: Glucophage, Fortamet, Glumetza Generic: Metformin, Metformin XR Sulfonylureas (Second Generation) Brand: Glucotrol, Amaryl, Diaβeta, Glynase Generic: Glipizide, Glipizide XL, Glimepiride, Glyburide Thiazolidinediones (TZDs) Brand: Actos, Avandia Generic: Pioglitazone, Rosiglitazone (no longer available) DPP-4 Inhibitors Brand: Januvia, Onglyza, Tradjenta, Nesina Generic: Sitagliptin, Saxagliptin, Linagliptin, Alogliptin SGLT2 Inhibitors Brand: Invokana, Farxiga, Jardiance, Steglatro, Brenzavvy Generic: Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin, Bexagliflozin GLP-1 Receptor Agonists Brand: Victoza, Trulicity, Ozempic, Rybelsus, Mounjaro (dual GIP/GLP-1) Generic: Liraglutide, Dulaglutide, Semaglutide, Tirzepatide Insulins (selected examples) Brand: Humalog, NovoLog, Apidra, Lantus, Basaglar, Levemir, Tresiba, Humulin N, Novolin N, Humulin R, Novolin R Generic: Insulin lispro, Insulin aspart, Insulin glulisine, Insulin glargine, Insulin detemir, Insulin degludec, NPH insulin, Regular insulin
In this episode of the Any Given Day podcast, registered dietitian Niamh Culhane (@nc_nutrition on Instagram) shares her journey from a casual fitness enthusiast to a competitive endurance athlete. She discusses the differences between dietitians and nutritionists, the importance of proper fuelling during endurance training, and the role of sugar in athletic performance. Niamh emphasises the significance of individualised nutrition, the impact of PCOS on dietary needs, and the necessity of strength training for overall health and longevity. She also provides practical tips for race day nutrition and encourages listeners to be proactive in their training and nutrition strategies.16:00 Introduction to Niamh Culhane18:41 Understanding Dietitian vs Nutritionist21:40 Niamh's Journey into Endurance Sports24:19 The Importance of Proper Nutrition in Training26:47 Recognising Signs of Underfuelling31:12 Individual Nutrition Needs for Endurance34:27 Practical Tips for Fuelling During Runs36:49 Caffeine: Benefits and Considerations45:29 Race Day Nutrition Strategies47:24 The Role of Caffeine in Performance48:16 Morning Nutrition for Runners51:14 Nutrition Strategies for Training Days52:18 Understanding PCOS and Its Impact on Nutrition56:58 Diet Manipulation and Intermittent Fasting61:25 Identifying Food Intolerances and Allergies65:08 Debunking Nutrition Myths68:35 The Importance of Strength Training72:31 Adapting Training to Different EnvironmentsYou can follow us on Instagram:@anygivenrundaypodcastThis episode is sponsored by ULTRAPURE Laboratories and their new Sports Recovery Kit. Ask for the ULTRAPURE Laboratories Muscle Recovery range in your local Pharmacy or Health Store or visit their new online storeUltrapurelabs.ie You can now get 20% off all Perform Nutrition products, including their new Carb Gels, using the code 'AGR' at checkoutPerformNutrition.com
Mayor Eric Adams says Thursday's arrest of a 16-year-old student at Cardozo High School in Bayside shows how easy access to firearms is putting New Yorkers at risk. Police say they found a loaded 9mm pistol with 13 rounds in the teen's backpack after the FBI flagged a threatening Instagram post. Meanwhile, New York pharmacies are administering updated COVID-19 vaccines ahead of federal guidance, following an executive order from Governor Hochul. Plus, 11 New York City elected officials were freed Friday after being arrested outside 26 Federal Plaza, where they were protesting immigration enforcement practices. WNYC's Arya Sunderam joins us to explain what happened and what it means.
This episode of Essential unpacks FDA confusion, California's latest compounding curveball, and pharma-fueled myths about GLP-1s. We spotlight APC's advocacy wins on Capitol Hill and why pharmacy tours pack political punch. Plus, the FDA's eyebrow-raising move to reclassify natural thyroid products — and why it matters for patients everywhere. News item about California reg: https://a4pc.org/news/this-one-little-word-could-trip-you-up Compounding primer: https://join.a4pc.org/hubfs/PDFs/Traditional-Pharmacy-Compounding-101.pdf?hsLang=en APC's guide to hosting a legislator: https://join.a4pc.org/hubfs/PDFs/2021-04_APC-Guidance-Hosting-Pharmacy-Visits.pdf APC in the News: https://a4pc.org/inthenews DTE grassroots campaign: https://compounding.com/thyroid
Send us a textWelcome back Rounds Table Listeners! We are back today with a special Rapid Fire Podcast. This week, Drs. Mike and John Fralick discuss some of the top papers from the 2025 European Society of Cardiology (ESC) Congress. Hot off the presses, here we go!Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias (0:00 - 5:23)Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction (5:24 - 10:23)RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults (10:24 - 16:09)Apixaban for Extended Treatment of Provoked Venous Thromboembolism (16:10 - 20:55)The Good Stuff (20:56 - 22:53):Thrombo Trial Files (https://thrombotrialfiles.substack.com/)John Candy: I Like Me at the Toronto International Film Festival The I'm Pharmacy podcast is now live on www.medicinepods.com Questions? Comments? Feedback? We'd love to hear from you! @roundstable @InternAtWork @MedicinePods
In this eye-opening episode, Dr. Lindsey Elmore exposes the chaos unfolding in the UK as Mounjaro (weight loss/diabetes medication) prices skyrocket 170% overnight—jumping from £92 to £330 per month. Discover how Eli Lilly's "European price matching" triggered panic buying, crashed pharmacy websites, and left patients spending over £1,000 to stockpile medications. Lindsey examines the real-world impact, even in the U.S.: supply shortages, hoarding behaviors, and the unfair advantage given to those who can afford to bulk-buy versus patients with genuine medical needs. A must-listen for understanding how arbitrary pharmaceutical pricing decisions affect real people's access to life-sustaining medications.Main Topic Introduction00:00-00:30: Discussion focuses on Mounjaro (weight loss/diabetes medication) pricing crisis in the UKThe Price Hike00:37-01:13: Massive 170% price increase starting September 1st, 2025Current price: £92/monthNew price: £330/month (up from planned £122/month)01:25-01:41: Eli Lilly justifies increase as "adjusting prices to match the rest of Europe"Pharmacy Response00:37 & 01:41-02:01: UK's largest online pharmacy "Pharmacy2U" freezes prices, then stops sales entirelyPanic Buying Crisis02:09-02:34: Patients stockpiling medications before price hikes02:22: Pharmacies offering 3, 6, or 9-month bundles02:44-02:59: Real examples: patients buying 7-8 pens, spending over £1,000 in panic purchases04:35: Pharmacy websites crashing from demandSupply Chain Impact02:59-03:24: Hoarding strains supply chains and prevents access for patients who truly need the medication03:24-03:44: Medical experts urge against hoarding injectable medications at homeCore Issues Identified03:51-04:12: Access and fairness concerns - distinguishing between medical necessity vs. cosmetic use05:37-05:57: Drug prices change "for no reason at all" with no patient input06:08-06:27: Need to prioritize patients who medically need medications over those who can afford to stockpileSolutions Proposed04:59-05:27: Work with legislators through existing Inflation Reduction Act framework06:27-06:55: Legislative action needed to control "absurd" arbitrary drug pricing, especially for life-sustaining medicationsEpisode Conclusion07:06-07:14: Show closing: encouraging wise health decisionsBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-lindsey-elmore-show--5952903/support.
It was truly an honor and a great pleasure to talk to a well-respected colleague and friend about his experience as both a pharmacist and an expert in the natural products field. He is a true embodiment of the Myth, Man and Legend. Tune in to learn more about filling in the gaps in the current healthcare climate by utilizing evidence-backed nutraceuticals. Dr. Jeffery A. Johnson, ND, PharmD, RPh, MBA is a dedicated healthcare professional and 30-year combat veteran of the U.S. Armed Forces (USAF). A graduate of Purdue University (BS-Pharm, 1978), he later earned his Doctor of Naturopathy (2000), Doctor of Pharmacy from the University of Kansas (2003), and an MBA. Throughout his career, Dr. Johnson has spent over three decades educating and consulting with healthcare professionals and clients on the integration of nutraceuticals into personal healthcare practices—highlighting both their benefits and potential challenges. Since retiring from active military service in 2017, he has continued his mission of promoting informed, holistic healthcare practices. He currently works part-time as a self-employed Consultant Pharmacist, offering expert guidance on nutraceuticals and overall wellness strategies. Connect with Jeffery via: Email: ntrxpathconsultants@outlook.com Linked In: Dr Jeffery A (Doc Pappy J) Johnson
For the last several decades, nutrition scientists have been debating the pros and cons of various dietary approaches. The Mediterranean diet has a lot of proponents, and we have interviewed some of them on The People's Pharmacy. Dr. Barry Popkin and Dr. Walter Willett endorse olive oil, whole grains, fruits and vegetables with only small […]